glp 1 and suicidal ideation Reassuring' findings suggest GLP-1 receptor agonists do not increase suicide risk Exploring the association between suicidal

Learn dietary changes, lifestyle adjustments, when to seek medical advice, and medication options to manage this common side effect effectively whilst continuing your treatment.

As global demand rises for effective metabolic therapies, GLP-1 drug development remains one of the fastest-growing segments in biopharma innovation

United by a shared mission to enhance obesity care, MYOS focuses on advancing clinical practice, raising awareness, and sharing expertise to improve the lives of people affected by obesity.

Achieve your weight loss goals with personalized GLP-1 at VIOS Compounding

Tiny appetite on Ozempic/Wegovy/Zepbound

The recently initiated large-sized FLOW trial investigating the effects of semaglutide on hard renal outcomes in patients with DKD will provide clarity whether GLP-1 receptor agonists may reduce the burden of DKD in addition to their other beneficial metabolic and cardiovascular effects.